Evidence map›Paper›PMID 41600987›Full record

ArticleVaccines2026

Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies.

Valeria Caputo, Martina Libera, Yailin Campos Mota, Kaito Nagashima, Ana Maria Moreno Martin, Claudia Maria Trombetta, Francesca Dapporto, Jarrod J Mousa, Emanuele Montomoli, Giuseppe A Sautto and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valeria CaputoPomona Ricerca S.r.l., 10122 Turin, Italy.ORCID 0000-0002-1997-6797
Martina LiberaPomona Ricerca S.r.l., 10122 Turin, Italy.
Yailin Campos MotaFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA.
Kaito NagashimaDepartment of Infectious Diseases, Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-7501-6651
Ana Maria Moreno MartinVirology Department, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, 25124 Brescia, Italy.ORCID 0000-0002-8497-9708
Claudia Maria TrombettaDepartment of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.ORCID 0000-0001-7229-9919
Francesca DapportoVisMederi S.r.l, 53100 Siena, Italy.
Jarrod J MousaDepartment of Infectious Diseases, Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0003-4709-2478
Emanuele MontomoliDepartment of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.ORCID 0000-0001-7595-4974
Giuseppe A SauttoFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL 34987, USA.ORCID 0000-0002-0273-2235
Roberta Antonia DiottiPomona Ricerca S.r.l., 10122 Turin, Italy.ORCID 0000-0002-7853-3224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

avian influenza virusimmunotherapyinfluenza virusmonoclonal antibodiesone health

Identifiers

PMID41600987
PMCPMC12846329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.